InsidersTradesSigma
Total declarations
Companies
▲ Purchases (8 ops.)
▼ Sales (2 ops.)
Insider track record
OtherDisclosed buys
8
Disclosed sells
2
T+90 hit rate
33%
T+90 mean return
-1.3%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Chen Bihua. Insider active across 4 companies, notably Erasca, Inc.. Cumulatively, 14 reports have been published. Breakdown: 8 buys · 2 sells. Total volume traded: €73.6m. History available since 26 July 2021. The latest transaction was disclosed on 13 February 2024 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations14 total
509,000 shares@ US$10.00100.0% of flowClass A Ordinary SharesSEC:0001213900-24-013534:0
58,839 shares@ US$59.89736.4% of flowClass A Ordinary SharesSEC:0000929638-23-002739:0
Ideal exit: 1 Jul 2024 (T+270)
74,911 shares@ US$57.377.8% of flowClass A Ordinary SharesSEC:0000929638-23-002692:0
Ideal exit: 28 Jun 2024 (T+270)
800,000 shares@ US$50.0070.2% of flowClass A Ordinary SharesSEC:0000929638-23-001943:0
Ideal exit: 26 Mar 2024 (T+270)
1,481 shares@ US$36.910.1% of flowClass A Ordinary SharesSEC:0000929638-23-001857:0
Ideal exit: 22 Mar 2024 (T+270)
400,000 shares@ US$30.00100.0% of flowCommon StockSEC:0000929638-23-001057:0
Ideal exit: 25 Dec 2023 (T+270)
446,881 shares@ US$19.363915.5% of flowClass A Ordinary SharesSEC:0000929638-23-000895:0
Ideal exit: 15 Dec 2023 (T+270)
307,692 shares@ US$6.5018.7% of flowCommon StockSEC:0000929638-22-001904:0
Ideal exit: 9 Sept 2023 (T+270)
307,692 shares@ US$6.5018.7% of flowCommon StockSEC:0000929638-22-001901:0
Ideal exit: 9 Sept 2023 (T+270)
2,785,000 shares0Class A Ordinary SharesSEC:0001213900-22-018749:0
200,000 shares@ US$18.7650.100% mcap50.0% of flowCommon StockSEC:0001567619-21-014882:0
200,000 shares@ US$18.76531.3% of flowCommon StockSEC:0001567619-21-014882
9,555,553 sharesCommon StockSEC:0001567619-21-013838:0
9,555,553 sharesCommon StockSEC:0001567619-21-013838
14 of 14 declarations
About Chen Bihua
Chen Bihua is a director at Erasca, Inc. and an insider at MoonLake Immunotherapeutics.
